Adalimumab/etanerceptAutoimmune renal disorders: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2014年 / 1528卷 / 1期

关键词：

D O I：

10.1007/s40278-014-5023-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：16 / 16

相关论文

共 50 条

[21] CloxacillinNeurological disorders in patients with renal impairment: 3 case reports
Reactions Weekly, 2008, 1222 (1) : 13 - 13
[22] FenofibrateKidney disorders in renal transplant recipients: 3 case reports
Reactions Weekly, 2005, 1034 (1) : 9 - 9
[23] Adalimumab/etanercept/infliximabDemyelinizing neurological disorders: 6 case reports
Reactions Weekly, 2014, 1510 (1) : 5 - 5
[24] Adalimumab/etanercept/infliximabPsoriasis: 3 case reports
Reactions Weekly, 2007, 1142 (1) : 7 - 7
[25] Adalimumab/infliximabTuberculosis and anaphylaxis: 3 case reports
Reactions Weekly, 2014, 1514 (1) : 7 - 7
[26] Adalimumab/etanerceptPolymyositis and dermatomyositis: 3 case reports
Reactions Weekly, 2018, 1683 (1) : 31 - 31
[27] Adalimumab/infliximabUveal melanoma: 3 case reports
Reactions Weekly, 2015, 1533 (1) : 24 - 24
[28] Adalimumab/infliximabAnorectal stenosis: 3 case reports
Reactions Weekly, 2011, 1335 (1) : 5 - 5
[29] Adalimumab/infliximabPulmonary tuberculosis: 3 case reports
Reactions Weekly, 2019, 1784 (1) : 17 - 17
[30] Adalimumab/infliximabCutaneous leishmaniasis: 3 case reports
Reactions Weekly, 2017, 1651 (1) : 19 - 19

← 1 2 3 4 5 →